The long-running patent dispute between Bright Data and Oxylabs reached a definitive conclusion on February 23, 2026, when the U.S. Supreme Court rejected Bright Data’s petition to review a lower court ruling, confirming the invalidity of two patents that Bright Data had used as the basis for its infringement claims against Oxylabs.
The dispute dates back to 2019 when Bright Data, then operating under the name Luminati, filed its initial lawsuit alleging that Oxylabs’ residential proxy technology infringed its patents.
After years of proceedings at the patent office and appellate courts, Oxylabs had obtained invalidity findings against claims in twelve Bright Data patents in total.
The Supreme Court’s refusal to hear the case means the Federal Circuit’s earlier ruling stands, and the patents in question are conclusively invalid.
Bright Data–Oxylabs Battle: The Decision Has Market-Wide Implications for the Proxy Industry
The ruling is significant not just for Oxylabs but for the broader proxy industry. Throughout the litigation, Bright Data had used its patent portfolio aggressively — suing or threatening competitors including NetNut, BiScience, and SOAX, and reportedly discouraging providers from operating in certain jurisdictions.
With the core patents now invalidated by the highest court in the land, other proxy providers can develop and market residential proxy products without fear of the same legal challenges.
The case also highlights the growing maturity of the proxy and web data industry, which now operates within an increasingly structured legal and regulatory environment.
For businesses relying on proxy services for data collection, this outcome removes a layer of supply chain legal risk that had been present in the market for several years.
More News To Read: